Friday, April 24, 2015

3 High-Yield Stocks Under $10 Paying Over 10%: MCC, EROC, EXP

There is a lot of appeal for low priced stocks to individual investors. Just from a feel good point of view, it can be more satisfying to buy 500 shares of a $10 stock than 66 shares of a $75 per share stock, even if your outlay is pretty much the same. Besides the satisfaction of owning a lot of shares, there are some valid total-return focused reasons for investors to seek out low priced stocks. (more)

Please share this article

Stocks To Watch: SGMO, DGLY, BBRY, IBIO, CA, MEIP, GALE

( click to enlarge )

Sangamo Biosciences, Inc. (NASDAQ:SGMO) Today's close on high volume confirms a trend change from downward to neutral. Will watch to see if it can break this horizontal resistance line. Technical indicators are showing signs of turning around. Over $16.20 would be buy trigger.

( click to enlarge )

Digital Ally, Inc. (NASDAQ:DGLY) could be in the early stages of a technical breakout (falling wedge pattern on daily). If the stock can break through 13.50 tomorrow, I expect to see heavy volume drive the stock higher.

( click to enlarge )

BlackBerry Ltd (NASDAQ:BBRY) After consolidating sideways the last few days with an upward bias, the stock broke out upwards today accompanied by a volume surge. Looks good for higher prices.

( click to enlarge )

Ibio Inc (NYSEMKT:IBIO) Volume starts to pick up again. Could make a nice move to the upside. MACD lines are going up. Keep this one on your watch list. A break of $1.12 with force might give IBIO room to $1.31.

( click to enlarge )

CA, Inc. (NASDAQ:CA) looks like it is getting ready to move. It has a good base at $31 which can be used as a stop loss for long position. On the upper side, the move is likely to accelerate above $32.50. Long setup.

( click to enlarge )

MEI Pharma Inc (NASDAQ:MEIP) rebounded from the support line located at $2.05 and closed the day near the highs, gaining 4.8% on the session. I'm watching the stock to breakout the resistance level at $2.44. The technical indicators still indicate a bullish tone in short-term.

( click to enlarge )

I think Galena Biopharma Inc (NASDAQ:GALE) stock has found a nice bottom here and it looks poised to post a rally from current levels. The Slow Stochastic just produced a new buy signal. I would watch for a breakout over the $1.46-1.48 region.

Please share this article

Man Who Predicted Collapse Of Euro Against Swiss Franc Warns World In For Another Major Surprise


kingworldnews.com / April 23, 2015
Today the man who remarkably predicted the collapse of the euro against the Swiss franc warned King World News that the world is in for another major surprise.
Egon von Greyerz:  “There is clearly apathy in the gold market now.  Gold has essentially gone sideways for the last couple of years.  Gold was at these levels in June of 2013.  So for two years gold has been trading sideways with some volatility….
Continue reading the Egon von Greyerz interview below…
READ MORE
Please share this article

Chart Industries, Inc. (NASDAQ: GTLS)

Chart Industries, Inc. manufactures and sells engineered equipment for the industrial gas, energy, and biomedical industries worldwide. The E&C segment primarily provides brazed aluminum heat exchangers, Core-in-Kettle heat exchangers, air-cooled heat exchangers, and cold boxes for natural gas processing, liquefied natural gas (LNG), and industrial gas applications. The D&S segment designs, manufactures, services, and maintains bulk and packaged gas cryogenic solutions for the storage, distribution, vaporization, and application of industrial gases; and offer cryogenic components, including vacuum insulated pipe, engineered bulk gas installations, specialty liquid nitrogen, end-use equipment, and cryogenic flow meters. The BioMedical Segment offers respiratory oxygen product line that comprises medical respiratory products, including liquid oxygen systems and stationary, transportable, and portable oxygen concentrators, which are primarily used for the in-home supplemental oxygen treatment of patients with chronic obstructive pulmonary diseases.
Take a look at the 1-year chart of Chart (NASDAQ: GTLS) below with the added notations:
1-year chart of Chart (NASDAQ: GTLS)
GTLS declined rapidly last summer and fall all the way down to it’s January low. The stock has since rallied more than 50 percent. Over the lat 6 months the $40 price level (blue) has become somewhat important to the stock. Not only was $40 a key support in October, as well as resistance in March and April, but that level has also been a recent support for the GTLS here as of late.

The Tale of the Tape: GTLS has a key level at $40. A trader could enter a long position on a pullback down to $40 with a stop placed under the level. However, if the stock were to break back below $40, a short trade could be made instead.
Please share this article